ArticleCancer immunology, immunotherapy : CII2021

Correction to: CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion.

Fei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.